wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41673629-2B93E23A-E6CA-40D4-93DF-3A5E68599DA2
Q41673629-2B93E23A-E6CA-40D4-93DF-3A5E68599DA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41673629-2B93E23A-E6CA-40D4-93DF-3A5E68599DA2
Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia.
P2860
Q41673629-2B93E23A-E6CA-40D4-93DF-3A5E68599DA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41673629-2B93E23A-E6CA-40D4-93DF-3A5E68599DA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbe8a5bbd56e7bbe3cb2bb0f0dec540acec5a6f6
P2860
Resistance to imatinib mesylate in chronic myeloid leukaemia.